Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients (PANTHER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00798070
Recruitment Status : Active, not recruiting
First Posted : November 25, 2008
Last Update Posted : September 3, 2020
Sponsor:
Collaborators:
Swedish Breast Cancer Group
Austrian Breast & Colorectal Cancer Study Group
German Breast Group
Information provided by (Responsible Party):
Prof Jonas Bergh, Karolinska University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : April 2016
Estimated Study Completion Date : January 2022
Publications of Results:
Other Publications:
Bergh J. Oral presentation, ASCO Annual Meeting 2016.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):